View Information Collection Request (ICR) Package

OMB Control No: 1117-0006	ICR Reference No: 200703-1117-006
Status: Historical Active	Previous ICR Reference No: 200603-1117-001
Agency/Subagency: DOJ/DEA	Agency Tracking No:
Title: Application for Individual manufacturing Quota for a Basic Class of Controlled Substance and for Ephedrine, Pseudoephedrine, and Phenylpropanolamine
Type of Information Collection: Reinstatement with change of a previously approved collection	Common Form ICR: No
Type of Review Request: Emergency	Approval Requested By: 03/31/2007
OIRA Conclusion Action: Approved without change	Conclusion Date: 03/29/2007
	Date Received in OIRA: 03/22/2007
Terms of Clearance: Approved consistent with the following terms of clearance: DEA is reminded to ensure that information collections covered by the Paperwork Reduction Act should be addressed timely during the development of rules by the Agency.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	09/30/2007	6 Months From Approved	05/31/2009
Responses	298	0	264
Time Burden (Hours)	150	0	132
Cost Burden (Dollars)	3,772	0	0

Abstract: 21 U.S.C. § 826 and 21 CFR §§ 1303.22 and 1315.22 require that any person who is registered to manufacture any basic class of controlled substances listed in Schedule I or II and who desires to manufacture a quantity of such class, or who desires to manufacture using the List I chemicals ephedrine, pseudoephedrine, or phenylpropanolamine, must apply on DEA Form 189 for a manufacturing quota for such quantity of such class or List I chemical.

Emergency Justfication: The Drug Enforcement Administration (DEA) is requesting emergency processing of the revision of Office of Management and Budget (OMB) information collections 1117-0006 Application for an Individual Manufacturing Quota for a Basic Class of Controlled Substance and of Ephedrine, Pseudoephedrine, and Phenylpropanolamine, 1117-0008 Application for Procurement Quota for Controlled Substances and Ephedrine, Pseudoephedrine, and Phenylpropanolamine, and approval of new information collection 1117-XXXX Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine as discussed below. The revision of these information collections and the approval of the new collection are associated with, and essential for the implementation of, the DEA Interim Rule with Request for comment entitled Import and Production Quotas for Certain List I Chemicals [Docket No. DEA-293, RIN 1117-AB08].

Authorizing Statute(s): US Code: 21 USC 826 Name of Law: Production Quotas for Controlled Substances

Citations for New Statutory Requirements: PL: Pub.L. 109 - 177 713 Name of Law: The Combat Methamphetamine Epidemic Act of 2005

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
1117-AB08	Final or interim final rulemaking

Federal Register Notices & Comments
Did the Agency receive public comments on this ICR? No

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion	Change Due to Adjustment in Estimate
Annual Number of Responses	298	264	1	33
Annual Time Burden (Hours)	150	132	1	17
Annual Cost Burden (Dollars)	3,772	0	-228	4,000

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Changing Regulations

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The Combat Methamphetamine Epidemic Act of 2005 (Title VII of Pub. L. 109-177) amended the Controlled Substances Act (21 U.S.C. 826) to require the establishment of production quotas for the List I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine. One firm will need to apply for an individual manufacturing quota to comply with the Controlled Substances Act as amended. The 3.5 hour annual burden increase is a result of this statutory change.

Annual Cost to Federal Government: $83,184

Does this IC contain surveys, censuses, or employ statistical methods? No

Is the Supporting Statement intended to be a Privacy Impact Assessment required by the E-Government Act of 2002? No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? Uncollected

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? Uncollected

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? Uncollected

Is this ICR related to the Pandemic Response? Uncollected

Agency Contact: Mark Caverly 202 307-7297

View ICR - OIRA Conclusion